Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity. Bartalena L, Marcocci C, Tanda ML, Marino M, et al. J Endocrinol Invest 2022;45:1603-1604.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bartalena L, Marcocci C, Tanda ML, Marino M, et al. Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity. J Endocrinol Invest 2022;45:1603-1604.
PMID: 35633498